TITAN MEDICAL INC (TMDI) Fundamental Analysis & Valuation

NASDAQ:TMDI • CA88830X8199

Current stock price

0.14 USD
-0.05 (-26.32%)
At close:
0.1241 USD
-0.02 (-11.36%)
After Hours:

This TMDI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TMDI Profitability Analysis

1.1 Basic Checks

  • TMDI had negative earnings in the past year.
  • TMDI had a negative operating cash flow in the past year.
TMDI Yearly Net Income VS EBIT VS OCF VS FCFTMDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -20M -40M

1.2 Ratios

  • TMDI has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TMDI Yearly ROA, ROE, ROICTMDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for TMDI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TMDI Yearly Profit, Operating, Gross MarginsTMDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. TMDI Health Analysis

2.1 Basic Checks

  • TMDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TMDI has more shares outstanding than it did 1 year ago.
  • TMDI has a better debt/assets ratio than last year.
TMDI Yearly Shares OutstandingTMDI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
TMDI Yearly Total Debt VS Total AssetsTMDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

  • TMDI has an Altman-Z score of -26.47. This is a bad value and indicates that TMDI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -26.47, TMDI is not doing good in the industry: 89.67% of the companies in the same industry are doing better.
  • TMDI has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • TMDI has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: TMDI outperforms 51.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -26.47
ROIC/WACCN/A
WACC8.45%
TMDI Yearly LT Debt VS Equity VS FCFTMDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M -40M

2.3 Liquidity

  • A Current Ratio of 1.41 indicates that TMDI should not have too much problems paying its short term obligations.
  • TMDI has a worse Current ratio (1.41) than 82.63% of its industry peers.
  • TMDI has a Quick Ratio of 1.41. This is a normal value and indicates that TMDI is financially healthy and should not expect problems in meeting its short term obligations.
  • TMDI's Quick ratio of 1.41 is on the low side compared to the rest of the industry. TMDI is outperformed by 69.01% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
TMDI Yearly Current Assets VS Current LiabilitesTMDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. TMDI Growth Analysis

3.1 Past

  • TMDI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.21%, which is quite impressive.
  • Looking at the last year, TMDI shows a very negative growth in Revenue. The Revenue has decreased by -50.23% in the last year.
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.64%
Revenue 1Y (TTM)-50.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TMDI Yearly Revenue VS EstimatesTMDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 5M 10M 15M 20M
TMDI Yearly EPS VS EstimatesTMDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. TMDI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TMDI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMDI Price Earnings VS Forward Price EarningsTMDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMDI Per share dataTMDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMDI Dividend Analysis

5.1 Amount

  • No dividends for TMDI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

TMDI Fundamentals: All Metrics, Ratios and Statistics

TITAN MEDICAL INC

NASDAQ:TMDI (3/9/2023, 8:00:01 PM)

After market: 0.1241 -0.02 (-11.36%)

0.14

-0.05 (-26.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)03-22
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.66M
Revenue(TTM)10.00M
Net Income(TTM)-21.04M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 3.18
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.09
BVpS0.06
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 98.02%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z -26.47
F-Score1
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)630.45%
Cap/Depr(5y)858.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-906.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1006.26%
OCF growth 3YN/A
OCF growth 5YN/A

TITAN MEDICAL INC / TMDI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TITAN MEDICAL INC (TMDI) stock?

ChartMill assigns a fundamental rating of 1 / 10 to TMDI.


What is the valuation status for TMDI stock?

ChartMill assigns a valuation rating of 1 / 10 to TITAN MEDICAL INC (TMDI). This can be considered as Overvalued.


Can you provide the profitability details for TITAN MEDICAL INC?

TITAN MEDICAL INC (TMDI) has a profitability rating of 0 / 10.